12:00 AM
Jun 11, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

External Trigeminal Nerve Stimulation: Phase I data

Researchers at the University of California, Los Angeles, reported data from 6 patients in the first cohort of a single-arm, open-label, U.S. Phase I trial in 20 patients with MDD co-occurring with PTSD that lasted >4 months showing that nightly 8-hour treatment with eTNS led to significant mean...

Read the full 230 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >